LPAR1 and major depressive disorder: The maLpar1-null mouse model exhibits depressive and anxious behaviors, which implies that researchers should develop drugs targeting Lpar1/Edg2 receptor as treatments for depression, mainly the anxious subtype (Moreno-Fernández et al., 2018).